LOS ANGELES--(BUSINESS WIRE)--DiaGenic ASA today presented prototypes for its early diagnostic test for breast cancer at the American Association for Cancer Research’s special Late-Breaking sessions at the 2007 Annual Meeting. Based on gene expression analysis using peripheral blood as sample material, the DiaGenic test trialed by samples from leading US and Scandinavian breast cancer specialists demonstrated high sensitivity and specificity on both prototypes.
